Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8686119 Variants of humanized immunomodulatory monoclonal antibodies

Patent 8686119 was granted and assigned to CureTech on April, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
‌
CureTech
Date Filed
July 23, 2012
Date of Patent
April 1, 2014
Patent Application Number
13556018
Patent Citations Received
‌
US Patent 12077554 CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
0
‌
US Patent 11746103 ALK-5 inhibitors and uses thereof
‌
US Patent 11932692 Methods of treating cancer pain by administering a PD-1 inhibitor
0
‌
US Patent 11981921 TIL expansion processes using specific cytokine combinations and/or AKTi treatment
0
‌
US Patent 11993651 Anti-lag-3 antibodies and methods of use thereof
0
‌
US Patent 11667890 Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
0
‌
US Patent 11712433 Compositions comprising PKM2 modulators and methods of treatment using the same
0
Patent Inventor Names
Michael Schickler
0
Rinat Rotem-Yehudar
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8686119
Patent Primary Examiner
‌
Sheela J. Huff

Find more entities like US Patent 8686119 Variants of humanized immunomodulatory monoclonal antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo